Skip to main content
Erschienen in: Clinical Rheumatology 4/2017

29.10.2016 | Original Article

Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population

verfasst von: Xiao-Ke Yang, Peng Li, Song Li, Chao Zhang, Bao-Zhu Li, Rui-Xue Leng, Hai-Feng Pan, Dong-Qing Ye

Erschienen in: Clinical Rheumatology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate the relationship between the single-nucleotide polymorphisms (SNPs) of interleukin 10 alpha receptor (IL10RA) gene and rheumatoid arthritis (RA) in a Chinese population. We examined 533 RA patients and 958 subjects as a control group. Three IL-10RA SNPs (rs9610, rs2229113 and rs3135932) were genotyped using TaqMan genotyping assays on Fluidigm 192.24 system. The IL-10RA rs9610 A allele was increased in patient group compared with control subjects (OR = 1.232, 95 % CI = 1.052–1.442, p = 0.030). Significant difference in genotype distribution was found in RA patients and controls (χ2 = 15.32, p < 0.001). We also discovered a statistical significance under the dominant model (GG + AG versus AA: OR = 0.676, 95 % CI = 0.546–0.837, p < 0.001). However, no significant difference was discovered in the recessive model (GG versus AG + AA: OR = 1.013, 95 % CI = 0.754–1.361, p = 0.932). Interestingly, significant differences were detected both in the allele and genotype frequencies of rs9610 between anti-CCP positive patients and anti-CCP negative patients (χ2 = 7.209, p = 0.007; χ2 = 9.061, p = 0.011; respectively). We also found a significant difference in genotype frequency at rs9610 in females compared with males (χ2 = 7.658, p = 0.022). Unfortunately, we failed to find any significant results between two IL-10RA SNPs (rs2229113 and rs3135932) and RA susceptibility. The findings suggest that IL-10RA rs9610 polymorphism might contribute to RA susceptibility.
Literatur
1.
Zurück zum Zitat McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2019CrossRefPubMed McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2019CrossRefPubMed
2.
Zurück zum Zitat Silman AJ, and Hochberg MC (1993) Epidemiology of the rheumatic diseases. Oxford University Press, New York 504:31–71 Silman AJ, and Hochberg MC (1993) Epidemiology of the rheumatic diseases. Oxford University Press, New York 504:31–71
3.
Zurück zum Zitat AJ M, Snieder H, AS R, Koskenvuo M, Kaprio J, Aho K, AJ S (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43(1):30–37CrossRef AJ M, Snieder H, AS R, Koskenvuo M, Kaprio J, Aho K, AJ S (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43(1):30–37CrossRef
4.
Zurück zum Zitat de Vries R (2011) Genetics of rheumatoid arthritis: time for a change! Curr Opin Rheumatol 23(3):227–232CrossRefPubMed de Vries R (2011) Genetics of rheumatoid arthritis: time for a change! Curr Opin Rheumatol 23(3):227–232CrossRefPubMed
5.
Zurück zum Zitat Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36:178–182CrossRefPubMed Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36:178–182CrossRefPubMed
6.
Zurück zum Zitat Kremer JM et al (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl JMed 349(20):1907–1915CrossRef Kremer JM et al (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl JMed 349(20):1907–1915CrossRef
7.
Zurück zum Zitat Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572–2581CrossRefPubMed Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR et al (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 350(25):2572–2581CrossRefPubMed
8.
Zurück zum Zitat Peng H, Wang W, Zhou M, Li R, Pan HF, Ye DQ (2013) Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin Rheumatol 32(9):1255–1266CrossRefPubMed Peng H, Wang W, Zhou M, Li R, Pan HF, Ye DQ (2013) Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin Rheumatol 32(9):1255–1266CrossRefPubMed
9.
Zurück zum Zitat Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM et al (1994) In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren’s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37:1647–1655CrossRefPubMed Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Fourrier BM et al (1994) In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren’s syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37:1647–1655CrossRefPubMed
10.
Zurück zum Zitat Kirkham BW, MN L, JP E, KM J, PA B, CS L et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis. Arthritis Rheum 54:1122–1131CrossRefPubMed Kirkham BW, MN L, JP E, KM J, PA B, CS L et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis. Arthritis Rheum 54:1122–1131CrossRefPubMed
11.
Zurück zum Zitat SP S, Thumboo J, Vasoo S, ST T, Tse C, KY F (2007) In vivo pro and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann Acad Med Singap 36:96–99 SP S, Thumboo J, Vasoo S, ST T, Tse C, KY F (2007) In vivo pro and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann Acad Med Singap 36:96–99
12.
Zurück zum Zitat Moore KW, de Waal MR, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765CrossRefPubMed Moore KW, de Waal MR, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765CrossRefPubMed
13.
Zurück zum Zitat Taga K, Tosato G (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148:1143–1148PubMed Taga K, Tosato G (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148:1143–1148PubMed
14.
Zurück zum Zitat JD W, EL L, CA C, Weiss K, Kovesdi I, JC G et al (1999) Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 162:3625–3632 JD W, EL L, CA C, Weiss K, Kovesdi I, JC G et al (1999) Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 162:3625–3632
15.
Zurück zum Zitat RP D, Dickensheets H, DS F (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interf Cytokine Res 19(6):563–573CrossRef RP D, Dickensheets H, DS F (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interf Cytokine Res 19(6):563–573CrossRef
16.
Zurück zum Zitat Kotenko SV, Pestka S (2000) Jak-stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19(21):2557–2565CrossRefPubMed Kotenko SV, Pestka S (2000) Jak-stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19(21):2557–2565CrossRefPubMed
17.
Zurück zum Zitat Logsdon NJ, Jones BC, Josephson K, Cook J, Walter MR (2002) Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. J Interf Cytokine Res 22(11):1099–1112CrossRef Logsdon NJ, Jones BC, Josephson K, Cook J, Walter MR (2002) Comparison of interleukin-22 and interleukin-10 soluble receptor complexes. J Interf Cytokine Res 22(11):1099–1112CrossRef
18.
Zurück zum Zitat Ding Y, Qin L, Zamarin D, Kotenko SV, Pestka S, Moore KW et al (2001) Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol 167(12):6884–6892CrossRefPubMed Ding Y, Qin L, Zamarin D, Kotenko SV, Pestka S, Moore KW et al (2001) Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation. J Immunol 167(12):6884–6892CrossRefPubMed
19.
Zurück zum Zitat Arnett F, Edworthy C (1988) The American rheumatism association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed Arnett F, Edworthy C (1988) The American rheumatism association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRefPubMed
20.
Zurück zum Zitat Taylor PC (2003) Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr Pharm Des 9:1095–1106CrossRefPubMed Taylor PC (2003) Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr Pharm Des 9:1095–1106CrossRefPubMed
21.
Zurück zum Zitat Lubberts E, van den Berg WB (2001) Potential of modulatory cytokines in the rheumatoid arthritis process. Drug News Perspect 14:517–522CrossRefPubMed Lubberts E, van den Berg WB (2001) Potential of modulatory cytokines in the rheumatoid arthritis process. Drug News Perspect 14:517–522CrossRefPubMed
22.
Zurück zum Zitat Wolk K, Witte E, Reineke U, Witte K, Friedrich M, Sterry W et al (2005) Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 6(1):8–18PubMed Wolk K, Witte E, Reineke U, Witte K, Friedrich M, Sterry W et al (2005) Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 6(1):8–18PubMed
23.
Zurück zum Zitat Reineke U, Schneider-Mergener J, Glaser RW, Stigler RD, Seifert M, Volk HD et al (1999) Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope. J Mol Recognit 12(4):242–248CrossRefPubMed Reineke U, Schneider-Mergener J, Glaser RW, Stigler RD, Seifert M, Volk HD et al (1999) Evidence for conformationally different states of interleukin-10: binding of a neutralizing antibody enhances accessibility of a hidden epitope. J Mol Recognit 12(4):242–248CrossRefPubMed
24.
Zurück zum Zitat Yoon SI, Logsdon NJ, Sheikh F, Donnelly RP, Walter MR (2006) Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J Biol Chem 281(46):35088–35096CrossRefPubMed Yoon SI, Logsdon NJ, Sheikh F, Donnelly RP, Walter MR (2006) Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. J Biol Chem 281(46):35088–35096CrossRefPubMed
25.
Zurück zum Zitat Neidhart M, Jüngel A, Ospelt C, Michel BA, Gay RE, Gay S (2005) Deficient expression of interleukin-10 receptor alpha chain in rheumatoid arthritis synovium: limitation of animal models of inflammation. Arthritis Rheum 52(10):3315–3318CrossRefPubMed Neidhart M, Jüngel A, Ospelt C, Michel BA, Gay RE, Gay S (2005) Deficient expression of interleukin-10 receptor alpha chain in rheumatoid arthritis synovium: limitation of animal models of inflammation. Arthritis Rheum 52(10):3315–3318CrossRefPubMed
26.
Zurück zum Zitat Hermann J, Gruber S, Neufeld JB, Grundtner P, Graninger M, Graninger WB et al (2009) IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 27(4):603–608PubMed Hermann J, Gruber S, Neufeld JB, Grundtner P, Graninger M, Graninger WB et al (2009) IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 27(4):603–608PubMed
27.
Zurück zum Zitat Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR et al (2013) Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study. Int J Cancer 133(1):201–213CrossRefPubMed Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR et al (2013) Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study. Int J Cancer 133(1):201–213CrossRefPubMed
28.
Zurück zum Zitat Bi X, Zheng T, Lan Q, Xu Z, Chen Y, Zhu G et al (2012) Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma. Am J Hematol 87(8):766–769CrossRefPubMedPubMedCentral Bi X, Zheng T, Lan Q, Xu Z, Chen Y, Zhu G et al (2012) Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma. Am J Hematol 87(8):766–769CrossRefPubMedPubMedCentral
Metadaten
Titel
Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population
verfasst von
Xiao-Ke Yang
Peng Li
Song Li
Chao Zhang
Bao-Zhu Li
Rui-Xue Leng
Hai-Feng Pan
Dong-Qing Ye
Publikationsdatum
29.10.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 4/2017
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3449-9

Weitere Artikel der Ausgabe 4/2017

Clinical Rheumatology 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.